Aaron Soto, VP at Sutro Biopharma to Speak at Protein Expression Mtg, Oct 23-24, 2014, Boston, MA.
Online PR News – 30-May-2014 – Boston, MA – Aaron K Soto, Vice President of Research at Sutro Biopharma, to Give a Presentation titled, “Design and Manufacture of Homogeneous Best-in-Class Antibody Drug Conjugates and Bispecifics by Cell-Free Protein Expression” at the Protein Expression, Purification & Characterization Conference, October 23 & 24, 2014, in Boston, MA, by GTCbio.
Dr. Sato has more than 10 years of industrial research experience in antibody, protein and peptide engineering. At Sutro, Aaron is the Vice President of Research and leads the team in the use of their bacterial extract system to produce high value protein therapeutics, such as ADC, bispecifics, and naked antibodies. Prior to joining Sutro, he was senior director of antibody engineering at OncoMed Pharmaceuticals, where his team discovered several antibodies for its clinical pipeline. Before this, he held director positions at Dyax Corp., where he oversaw multiple external collaborations with major pharmaceutical companies.
Dr. Sato holds many patents and is the author of numerous peer-reviewed publications. He received a doctorate in chemistry from Massachusetts Institute of Technology and a bachelor's degree in chemistry from the University of Puget Sound.
For more information, please visit www.gtcbio.com/proteinexpression
The Protein Expression, Purification & Characterization Conference will be a premier conference that will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities. A balance of both academic and industry experts will facilitate discussion on expression of difficult proteins, new methods of purification, production of reagents for biologics programs, and protein analytical tools and computational methods.
This conference is part of the Protein Discovery Summit 2014, which consists of the following co-located conferences:
1) 3rd Protein Kinases in Drug Discovery
2) Protein Expression, Characterization & Purification
3) 2nd Antibody & Protein Therapeutics
4) 2nd Protein-Protein Interaction
For more information, please visit www.gtcbio.com/proteinexpression/agenda